Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELARL PHARMACIE MOLLICONE : revenue, balance sheet and financial ratios

SELARL PHARMACIE MOLLICONE is a French company founded 8 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in ROCHE-LA-MOLIERE (42230), this company of category PME shows in 2025 a net income positive of 80 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMACIE MOLLICONE (SIREN 838604700)
Indicator 2025 2024 2023 2022 2021 2020 2019
Revenue N/C N/C N/C N/C N/C N/C N/C
Net income 80 409 € 101 511 € 148 315 € 209 145 € 150 305 € 134 336 € 58 239 €
EBITDA N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2025, SELARL PHARMACIE MOLLICONE generates positive net income of 80 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2019-2025: 58 k€ -> 80 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

80 409 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 146%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 36%. The balance between equity and debt is satisfactory.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

146.099%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

35.668%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

38.2%

Solvency indicators evolution
SELARL PHARMACIE MOLLICONE

Sector positioning

Debt ratio
146.1 2025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Average +16 pts over 3 years

In 2025, the debt ratio of SELARL PHARMACIE MOLLICONE (146.10) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
35.67% 2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Average -16 pts over 3 years

In 2025, the financial autonomy of SELARL PHARMACIE MOLLICONE (35.7%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 197.77. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

197.772

Liquidity indicators evolution
SELARL PHARMACIE MOLLICONE

Sector positioning

Liquidity ratio
197.77 2025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Good -20 pts over 3 years

In 2025, the liquidity ratio of SELARL PHARMACIE MOLLICONE (197.77) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Positioning of SELARL PHARMACIE MOLLICONE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of SELARL PHARMACIE MOLLICONE is estimated at 1 277 306 € (range 866 786€ - 2 004 269€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
866k€ 1277k€ 2004k€
1 277 306 € Range: 866 786€ - 2 004 269€
NAF 5 année 2025

Valuation method used

Net Income Multiple
80 409 € × 15.9x = 1 277 307 €
Range: 866 786€ - 2 004 270€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE MOLLICONE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE MOLLICONE

What is the revenue of SELARL PHARMACIE MOLLICONE ?

The revenue of SELARL PHARMACIE MOLLICONE is not publicly disclosed (confidential accounts filed with INPI).

Is SELARL PHARMACIE MOLLICONE profitable?

Yes, SELARL PHARMACIE MOLLICONE generated a net profit of 80 k€ in 2025.

Where is the headquarters of SELARL PHARMACIE MOLLICONE ?

The headquarters of SELARL PHARMACIE MOLLICONE is located in ROCHE-LA-MOLIERE (42230), in the department Loire.

Where to find the tax return of SELARL PHARMACIE MOLLICONE ?

The tax return of SELARL PHARMACIE MOLLICONE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE MOLLICONE operate?

SELARL PHARMACIE MOLLICONE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.